PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27638852-0	2016	The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan.	Valsartan	101-110	angiotensin I converting enzyme	Homo sapiens	19-22	
27638852-1	2016	INTRODUCTION: To investigate the associations between the insertion/deletion (I/D) polymorphisms in the angiotensin converting enzyme (ACE) gene and susceptibility to diabetic kidney disease (DKD); and the efficacy of valsartan in reducing the urine protein in Type 2 diabetes mellitus (T2DM) patients.	Valsartan	218-227	angiotensin I converting enzyme	Homo sapiens	104-133	
27638852-1	2016	INTRODUCTION: To investigate the associations between the insertion/deletion (I/D) polymorphisms in the angiotensin converting enzyme (ACE) gene and susceptibility to diabetic kidney disease (DKD); and the efficacy of valsartan in reducing the urine protein in Type 2 diabetes mellitus (T2DM) patients.	Valsartan	218-227	angiotensin I converting enzyme	Homo sapiens	135-138	
27638852-11	2016	Furthermore, the ACE I/D polymorphism influenced the renoprotective response to valsartan: Patients with the DD genotype benefitted the most from this treatment.	Valsartan	80-89	angiotensin I converting enzyme	Homo sapiens	17-20